IOP - Instituto de Oncologia do Parana

Curitiba 80530-010

0 studies enrolling now · 1 studies all time

What they study most

Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement

Studies at this site

• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now